4.7 Article

Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease

期刊

ALZHEIMERS & DEMENTIA
卷 11, 期 9, 页码 1080-1089

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jalz.2014.09.002

关键词

Mild cognitive impairment (MCI); Alzheimer's disease; Dementia; Everyday function; Daily functioning; Instrumental activities of daily living; Informant-report; Self-report; Biomarkers; ADNI

资金

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI
  2. National Institute of Health Grant ) [U01 AG024904]
  3. Alzheimer's Disease Neuroimaging Initiative-2 (ADNI-2)
  4. Alzheimer's Disease Neuroimaging Initiative Grand Opportunity (ADNI-GO)
  5. National Institute on Aging
  6. National Institute of Biomedical Imaging and Bioengineering
  7. Alzheimer's Association
  8. Alzheimer's Drug Discovery Foundation
  9. BioClinica, Inc.
  10. Biogen Idec Inc.
  11. Bristol-Myers Squibb Company
  12. Eisai Inc.
  13. Elan Pharmaceuticals, Inc.
  14. Eli Lilly and Company
  15. F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
  16. GE Healthcare
  17. Innogenetics, N.V.
  18. IXICO Ltd.
  19. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  20. Johnson & Johnson Pharmaceutical Research & Development LLC.
  21. Medpace, Inc.
  22. Merck Co., Inc.
  23. Meso Scale Diagnostics, LLC.
  24. NeuroRx Research
  25. Novartis Pharmaceuticals Corporation
  26. Pfizer Inc.
  27. Piramal Imaging
  28. Servier
  29. Synarc Inc.
  30. Takeda Pharmaceutical Company
  31. Canadian Institutes of Health Research
  32. NIH grants [P30 AG010129, K01 AG030514, R01AG19771, P30AG10133, P30 AG 10129, RO1 AG031252]

向作者/读者索取更多资源

It is recognized that individuals with mild cognitive impairment (MCI) already demonstrate difficulty in aspects of daily functioning, which predicts disease progression. This study examined the relationship between self-versus informant-report of functional ability, and how those reports relate to objective disease measures across the disease spectrum (i.e. cognitively normal, MCI, Alzheimer's disease). A total of 1080 subjects with self- and/or informant-rated Everyday Cognition questionnaires were included. Objective measures included cognitive functioning, structural brain atrophy, cerebrospinal fluid abnormalities, and a marker of amyloid deposition using positron emission tomography with [F-18]AV45 (florbetapir). Overall, informant-report was consistently more associated with objective markers of disease than self-report although self-reported functional status may still have some utility in early disease. Published by Elsevier Inc. on behalf of the Alzheimer's Association.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据